טוען...
Thymosins in multiple sclerosis and its experimental models: moving from basic to clinical application
Background: Multiple sclerosis (MS) afflicts more than 2.5 million individuals worldwide and this number is increasing over time. Within the past years, a great number of disease-modifying treatments have emerged; however, efficacious treatments and a cure for MS await discovery. Thymosins, soluble...
שמור ב:
| הוצא לאור ב: | Mult Scler Relat Disord |
|---|---|
| Main Authors: | , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier B.V.
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7104151/ https://ncbi.nlm.nih.gov/pubmed/30317071 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.msard.2018.09.035 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|